Virbac S.A.
VRBCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $3 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $3 | $3 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 6.3% | -1.2% | 10.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.4% | 65.5% | 68.7% | 64.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 21.2% | 15.5% | 24% | 15.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 11.2% | 7.3% | 13.5% | 7.3% |
| EPS Diluted | 9.83 | 6.05 | 11.29 | 5.53 |
| % Growth | 62.5% | -46.4% | 104.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |